Sunday, June 2, 2019
- 4:30pm-4:42pm
-
Antirejection Efficacy in De Novo Renal Transplant Recipients Receiving Everolimus with a Reduced-Exposure Calcineurin Inhibitor-Based Regimen: 24-Month Results from the TRANSFORM Study
Concurrent Session: Kidney Immunosuppression: Novel Regimens and Drug Minimization I • Veterans Auditorium
- 4:30pm-4:42pm
-
Eculizumab Deposition in Renal Transplants
- 4:30pm-4:42pm
-
Efficacy and Safety with Empagliflozin in Renal Transplant Recipients with Post-Transplant Diabetes Mellitus
- 4:30pm-4:42pm
-
Evaluation of Influenza Virus Antibody Response in Naturally Infected and Vaccinated Transplant Recipients by Protein Microarray
Concurrent Session: Vaccines and Viruses • Room 313
- 4:30pm-4:42pm
-
Mismatched Epitope and De Novo DSA Development: An Analysis of the Benefit and Benefit-EXT Renal Transplant Cohorts
- 4:30pm-4:42pm
-
Opioid and Benzodiazepine Use in Lung Transplant Candidates: A National Survey of Policies and Practices
- «Previous Page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- …
- 56
- Next Page»